Alexandria Stroke and Neurointervention Center
Alexandria, Egypt
NCT Number: NCT07257146
This study aims to identify and quantify the non-clinical barriers (social, transport, and knowledge-based) that delay patient arrival at the hospital during an Acute Ischemic Stroke. By utilizing a multimodal approach that combines a validated patient questionnaire (SABI Tool), Geographic Information Systems (GIS) analysis, and biological markers (infarct volume), the investigators seek to develop a Machine Learning model capable of predicting high-risk phenotypes for pre-hospital delay. The ultimate goal is to validate "Social Determinants of Health" against objective biological outcomes.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Alexandria, Egypt
Despite advances in stroke reperfusion therapies (thrombectomy and thrombolysis), pre-hospital delays remain the primary cause of preventable disability. Current triage systems rely heavily on clinical severity scales but fail to account for Social Determinants of Health (SDOH) that dictate onset-to-door times.
This is a prospective, observational, single-center cohort study designed to validate the "Stroke Access Barrier Identification" (SABI) tool using a "Triangulation Strategy."
The study employs three distinct data sources:
Subjective: Administration of the SABI questionnaire to assess cognitive, physical, and structural barriers.
Geospatial (Objective): Network-based GIS analysis to calculate precise drive-time isochrones and public transit density, validating patient reports of transport difficulty.
Biological (The "Anchor"): Correlation of barrier scores with Infarct Core Volume (measured via CT-Perfusion/MRI) and 90-day functional outcomes.
Data will be processed using interpretable Machine Learning algorithms (Random Forest / XGBoost) and SHAP (SHapley Additive exPlanations) values to identify the specific social features that most strongly predict delayed presentation and increased brain tissue loss.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patient or Legally Authorized Representative (LAR) able to provide informed consent.
Verifiable residential address (required for GIS analysis).
Exclusion criteria
Implementation of targeted barrier-reduction strategies at selected stroke centers based on baseline SABI profiles. The primary intervention consists of EMS Training Programs focused on stroke recognition, triage protocols, and rapid transport to Mechanical Thrombectomy (MT) capable centers.
Comparator/Control: Pre-intervention period (historical control) where standard of care was utilized without the targeted SABI-guided training.
Post-Intervention: Assessment of MT utilization rates and SABI scores following the implementation of the training modules.
Time frame: Baseline (Admission Imaging)
To validate if subjective barriers correlate with objective physiological damage. The total score on the SABI questionnaire (Scale 0-100, higher scores indicate higher barriers) will be correlated with the admission Infarct Core Volume (measured in milliliters via automated CT-Perfusion software).
Time frame: Baseline through Study Completion (12 months)
Sensitivity and Specificity of the XGBoost Machine Learning model in classifying patients as "Early Arrivers" vs. "Late Arrivers" (defined as >4.5 hours from Last Known Well) using combined clinical and SABI variables.
Time frame: Baseline
Cohen's Kappa coefficient measuring agreement between patient-reported "Difficulty with Transport" (SABI Domain 2) and objective "Network Drive Time" calculated via ArcGIS using historical traffic data.
Time frame: 90 Days post-discharge
Correlation between baseline SABI Barrier Score and the Modified Rankin Scale (mRS) score at 90 days. The mRS is a scale from 0 (no symptoms) to 6 (dead).
Middle East North Africa Stroke and Interventional Neurotherapies Organization
Other
Machine Learning Identification of Modifiable Access Barriers in Acute Ischemic Stroke: A Multimodal "Digital Phenotyping" Approach
Acronym: Smart-SABI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03229148
Anesthesia, Brain Diseases
Clermont-Ferrand, Auvergne, France
View Trial DetailsNCT07526649
Acute Ischemic Stroke, Brain Diseases
Grafton, Auckland, New Zealand
View Trial DetailsNCT07292974
Brain Diseases, Cardiovascular Diseases
View Trial DetailsNCT05930145
Arterial Occlusive Diseases, Brain Diseases
Essen, Germany
View Trial Details